---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-25-000272"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:37:17.601432+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Zoetis Q3 adjusted EPS $1.70 (+8%); revenue $2.4B (+4% organic); FY guidance narrowed

## Summary
- Q3 revenue $2.4B (+1% reported; +4% organic operational); net income $721M, $1.63 diluted EPS (+9% YoY).
- Adjusted net income $754M, $1.70 adjusted diluted EPS (+8% reported; +12% organic operational).
- U.S. segment revenue $1.3B (-2% reported, +3% organic); International $1.1B (+3% reported, +6% organic).
- Updated FY2025 revenue guidance $9.400-9.475B (5.5-6.5% organic growth); adjusted EPS $6.30-6.40 maintained.
- Regulatory milestones: Lenivia approved in Canada/EU for canine OA pain; Portela approved in EU for feline OA.

## SEC filing metadata
- accession: 0001555280-25-000272
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528025000272/0001555280-25-000272-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528025000272/zts-20251104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-25-000272
- JSON: https://secwatch.observer/filing/0001555280-25-000272.json
- Plain text: https://secwatch.observer/filing/0001555280-25-000272.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.